Table 2a. Correlation between baseline factors and serum sodium, cohort A.

	Serum sodium
	Low (N=24)	Normal (N=96)	P
MSKCC (N=115)	N (%)	N (%)	0.001
Favourable (N=15)	0 (0)	15 (16)
Intermediate (N=65)	8 (36)	57 (61)
Poor (N=35)	14 (64)	21 (23)
Weight loss (N=119)			0.001
⩽10% (N=95)	13 (54)	82 (86)
>10% (N=24)	11 (46)	13 (14)
Performance status (N=120)			0.000
0.1 (N=91)	8 (33)	83 (86)
2+ (N=29)	16 (67)	13 (14)
Number of sites (N=120)			0.020
1.2 (N=52)	5 (21)	47 (49)
3+ (N=68)	19 (79)	49 (51)
Primary tumor in place (N=120)			0.039
No (N=59)	7 (29)	52 (54)
Yes (N=61)	17 (71)	44 (46)
Leukocytes (N=120)			0.029
Normal (N=92)	14 (58)	78 (81)
High (N=28)	10 (42)	18 (19)
Albumin (N=119)			0.000
Normal (N=68)	2 (8)	66 (69)
Low (N=51)	22 (92)	29 (31)
Alkalic phosphatase (N=118)			0.004
Normal (N=71)	7 (29)	64 (67)
High (N=47)	15 (63)	32 (33)
Haemoglobin (N=120)			0.000
Normal (N=56)	2 (8)	54 (56)
Low (N=64)	22 (92)	42 (44)